Ocular Genetics and Gene Therapy explores the genetic and molecular basis of inherited eye diseases and the development of targeted genomic treatments. The session covers genomic diagnosis, inherited retinal and optic nerve disorders, genetic counseling, gene replacement, gene editing, molecular technologies, and advances toward personalized genetic therapies.
Abstract Scope and Participation
Submissions may address inherited eye disorders, genomics, molecular diagnostics, genetic variants, counseling, gene therapy, gene editing, vectors, and therapeutic outcomes. Ophthalmologists, geneticists, molecular scientists, researchers, counselors, and professionals involved in genomic medicine and therapeutic development are encouraged to participate.







Title : Why a paediatric orthoptic oncology service matters
Shenika Tailor, University Hospitals of Leicester NHS Trust, United Kingdom
Title : Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Tim Jackson, King’s College London, United Kingdom